EV Biologics, Inc. (OTCMKTS:YECO – Get Free Report)’s stock price shot up 28.5% during mid-day trading on Wednesday . The company traded as high as $0.13 and last traded at $0.13. 41,000 shares traded hands during trading, an increase of 271% from the average session volume of 11,050 shares. The stock had previously closed at $0.10.
EV Biologics Stock Performance
The firm has a 50-day simple moving average of $0.16 and a 200 day simple moving average of $0.22.
About EV Biologics
EV Biologics, Inc, a biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics. It is involved in developing vaccines, therapeutics, and cures based on its proprietary multifunctional EV platform. The company also focuses on developing human mesenchymal and other stem cell, and cell-derived products to market in the cosmetic and biopharmaceutical spaces.
Recommended Stories
- Five stocks we like better than EV Biologics
- How to Most Effectively Use the MarketBeat Earnings Screener
- 3 Must-Have ETFs Set to Dominate This Quarter
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Seeking Stability? These 3 Stocks Offer Strong Potential
- What is a Low P/E Ratio and What Does it Tell Investors?
- Trade War Bargain Stocks: Top 3 Picks Too Good to Pass Up
Receive News & Ratings for EV Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EV Biologics and related companies with MarketBeat.com's FREE daily email newsletter.
